2020
DOI: 10.21608/jcbr.2020.29939.1038
|View full text |Cite
|
Sign up to set email alerts
|

The Programmed Death-1 Receptor, Programmed Death-1 Ligand (PD-1/PD-L1) and Apoptosis in Breast Cancer Patients: A potential Mechanism of Immune Escape

Abstract: Background: Interaction between programmed cell death ligand-1 (PD-L1) and its receptor PD-1 is a major inhibitory pathway in maintaining an immunosuppressive tumor microenvironment. The expression of PD-L1 in various solid tumors is proposed to function in preventing T-cell mediated tumor killing, and activating tumor -suppressive cell populations through different mechanisms. The B-cell Lymphoma-2 (Bcl-2) is a key anti-apoptotic protein has been described as mediators of cancer progression. The expression of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 40 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?